VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 53 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443 | -99.3% | 114 | -98.4% | 0.00% | – |
| Q1 2022 | $60,000 | -20.0% | 7,323 | -10.3% | 0.00% | – |
| Q4 2021 | $75,000 | -22.7% | 8,161 | +5.4% | 0.00% | – |
| Q3 2021 | $97,000 | +6.6% | 7,741 | -3.9% | 0.00% | – |
| Q2 2021 | $91,000 | -27.8% | 8,058 | -3.0% | 0.00% | – |
| Q1 2021 | $126,000 | +21.2% | 8,310 | -8.3% | 0.00% | – |
| Q4 2020 | $104,000 | +103.9% | 9,063 | +38.5% | 0.00% | – |
| Q3 2020 | $51,000 | -21.5% | 6,546 | +10.2% | 0.00% | – |
| Q2 2020 | $65,000 | +41.3% | 5,942 | +41.8% | 0.00% | – |
| Q1 2020 | $46,000 | -33.3% | 4,191 | -5.8% | 0.00% | – |
| Q4 2019 | $69,000 | +35.3% | 4,449 | +24.9% | 0.00% | – |
| Q3 2019 | $51,000 | -55.3% | 3,563 | -64.0% | 0.00% | – |
| Q2 2019 | $114,000 | -20.8% | 9,901 | -26.5% | 0.00% | – |
| Q1 2019 | $144,000 | +136.1% | 13,462 | +77.6% | 0.00% | – |
| Q4 2018 | $61,000 | -84.8% | 7,582 | -69.5% | 0.00% | – |
| Q3 2018 | $402,000 | – | 24,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |